Despite publicity about their dangers and overuse, medical doctors have
steadily increased their prescriptions of stimulants and antidepressant
medications to treat ADHD (attention-deficit/hyperactivity disorder) and
depression in children – some as much as 195%!
The most commonly prescribed psychotropic classes of drugs – central
nervous system stimulants (CNSSs) and selective serotonin reuptake
inhibitors (SSRIs) –- increased by 26% and 62% respectively. The
shocking information is contained in a report based on a study funded by
the Agency for Healthcare Research and Quality (AHRQ) that covered the
years 1995 to 1999, published in a recent issue of Ambulatory
Pediatrics.
Researchers at the Center for Health Care Policy and Evaluation,
UnitedHealth Group, with support from AHRQ's Center for Education and
Research on Therapeutics at the University of North Carolina, studied how
four therapeutic drug classes used to treat ADHD and depression in youth
– CNSSs, SSRIs, tricyclic antidepressants (TCAs), and other
antidepressants – vary in use over time by age, gender, geographic
region, and prescribing physician.
They used pharmacy and enrollment data from six geographically diverse
model employer-insured health plans. Researchers examined trends in
physician prescribing practices of psychotropics for youth, but did not
focus on the appropriateness of prescribing patterns or quality-of-care
models.
The study also found:
*** For CNSS patient use, the proportion of Ritalin users decreased,
while the proportion of Adderall users increased.
*** Among all children under 20 years, those receiving both CNSSs and
SSRIs almost doubled from 1.4 to 2.6 per 1,000 over five years.
*** The use of antidepressants other than SSRIs or TCAs by physicians
for their patients increased by 195% overall.
*** A child's first prescription for each CNSS prescribed came from a
pediatrician 50% of the time and by a family practitioner 20% of the time.
The first prescription for each SSRI prescribed was most likely given by a
psychiatrist, although the proportion decreased from 56 to 44% during the
study.
SOURCE: "Ambulatory Use of Psychotropics by
Employer-Insured Children and Adolescents in a National Managed Care
Organization," Ambulatory Pediatrics, March-April 2002.